Sign In
Buy AMRX
$12.88
+0.225 (+1.78%)
At Close: Jun 03, 2026
Is Amneal Pharmaceuticals (AMRX) Stock Outpacing Its Medical Peers This Year?
10:40am, Thursday, 16'th Jan 2025
Here is how Amneal Pharmaceuticals (AMRX) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.
Amneal (AMRX) Upgraded to Strong Buy: Here's Why
01:00pm, Wednesday, 08'th Jan 2025
Amneal (AMRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist.
AMNEAL PHARMACEUTICALS, INC. (AMRX) Hit a 52 Week High, Can the Run Continue?
10:15am, Tuesday, 12'th Nov 2024
Amneal (AMRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Amneal Pharmaceuticals, Inc. (AMRX) Q3 2024 Earnings Call Transcript
03:27pm, Friday, 08'th Nov 2024
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX ) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Tony DiMeo - Head of Investor Relations Chirag Patel - President & Co-Chie
Amneal (AMRX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
10:36am, Friday, 08'th Nov 2024
While the top- and bottom-line numbers for Amneal (AMRX) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compar
Amneal Pharmaceuticals (AMRX) Surpasses Q3 Earnings and Revenue Estimates
08:10am, Friday, 08'th Nov 2024
Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.19 per share a year ago.
Amneal Reports Third Quarter 2024 Financial Results
06:00am, Friday, 08'th Nov 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Reports Third Quarter 2024 Financial Results.
Amneal (AMRX) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:20am, Wednesday, 06'th Nov 2024
Evaluate the expected performance of Amneal (AMRX) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
5 Stocks Backed by High Efficiency for Solid Gains Amid Volatility
08:05am, Tuesday, 05'th Nov 2024
Invest in stocks of AMRX, CRON, CSV, BFST and APH to tap their high-efficiency levels.
Earnings Preview: Amneal Pharmaceuticals (AMRX) Q3 Earnings Expected to Decline
11:06am, Friday, 01'st Nov 2024
Amneal (AMRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How to Find Great Cheap Stocks Under $10 to Buy in October
04:01pm, Tuesday, 15'th Oct 2024
On top of their cheap price tags, Wall Street analysts are high on all of these stocks and their improving earnings outlooks earn them strong Zacks Ranks.
Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year?
10:40am, Monday, 14'th Oct 2024
Here is how Amneal Pharmaceuticals (AMRX) and Astrazeneca (AZN) have performed compared to their sector so far this year.
Amneal to Report Third Quarter 2024 Results on November 8, 2024
04:05pm, Tuesday, 08'th Oct 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal to Report Third Quarter 2024 Results on November 8, 2024.
BRIDGEWATER, N.J. & NEW YORK--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, and Metsera, Inc. (“Metsera”), a cl
